News

Exploring the Benefits of the Honey Gardens and ZAND Immunity Merger

Exploring the Benefits of the Honey Gardens and ZAND Immunity Merger

Better Being Co Merges Honey Gardens and ZAND Immunity

The recent merger between Honey Gardens and ZAND Immunity marks a significant step toward enhancing whole-body wellness solutions through the healing power of bee products.

Strategic Focus on Apitherapy

With this merger, the focus remains firmly on apitherapy and immunity support products, reflecting the growing consumer interest in natural health solutions. This union is set to deliver a comprehensive range of products derived from the hives, emphasizing their natural healing properties.

Products to Look Forward To

The newly formed product line, now known as Honey Gardens by ZAND Bee Therapy, will continue to feature a variety of apitherapy products. This includes offerings such as propolis, royal jelly, flavorful drinks, and syrups. The legacy of quality and efficacy established by Vermont Beekeeper Todd Hard in the 1960s will continue, but with an updated packaging to reflect its new chapter.

Excitement Among Leadership

“This merger gives Honey Gardens a new space to live and thrive,” said Kyle Garner, president and CCO of Better Being Co. “We now have a great opportunity and resources to grow both the brand and product lines—supporting the wellness needs our customers care about most.” Such enthusiasm from leadership underscores the expansive possibilities that this merger will bring.

Sustained Commitment to Quality

ZAND Immunity will persist in offering a reliable range of whole-body wellness solutions beyond apitherapy. This includes beloved products such as lozenges and syrups, all crafted with utmost care and rigorous testing to ensure the wellness support customers expect.

A Legacy of Natural Health

As a pioneer in bee therapy during the 1960s, Todd Hardy recognized the extensive health benefits of honey. Today, Honey Gardens by ZAND Bee Therapy carries on this legacy, extending its portfolio to include a diverse range of apitherapy products that complement those offered by ZAND Immunity, significantly enhancing their health benefits.

About Honey Gardens by ZAND Bee Therapy

The combination of traditional beekeeping wisdom and modern health solutions positions Honey Gardens by ZAND Bee Therapy as a leader in the natural health market. From propolis and royal jelly to syrups, the offerings remain a testament to the benefits of bee products in promoting overall wellness.

About ZAND Immunity

Since its inception in 1978, ZAND Immunity has been dedicated to providing consumers with high-quality supplements that harness the earth's natural strength. With a commitment to sourcing only the finest herbs and nutrients, ZAND continues to craft a variety of products designed to help individuals maintain their health and resilience.

Frequently Asked Questions

What is the significance of the merger between Honey Gardens and ZAND Immunity?

The merger enhances their focus on wellness solutions by combining product lines and expertise in natural health.

What products does Honey Gardens by ZAND Bee Therapy offer?

They offer a range of apitherapy products, including propolis, royal jelly, syrups, and drinks that support wellness.

Who leads Better Being Co.?

Kyle Garner is the president and CCO of Better Being Co, emphasizing innovative growth opportunities.

When was ZAND Immunity established?

ZAND Immunity was established in 1978 and has been dedicated to crafting quality natural health products since.

How does ZAND Immunity ensure product quality?

Every ingredient is meticulously tested and every supplement is carefully crafted to guarantee customer satisfaction and wellness support.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fermi's Leadership Saga: Proxy Wars and Power Struggles

Updated Category News Views 61

Unfolding the Drama at Fermi (NASDAQ:FRMI) You'd think you were watching a suspense drama unfold, not an annual shareholder meeting report. The co-founder of Fermi, Toby Neugebauer, stepped into the spotlight, throwing shade at Rick Perry and the board's shaky status quo. Pitting Shareholders Against the Board Neugebauer isn't mincing words about the current state of...

Continue Reading
Senstar Boasts Robust Q3 Growth Amid Global Demand

Updated Category News Views 83

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

Continue Reading
Research Solutions Set to Reveal Q1 FY27 Results

Updated Category News Views 89

Understanding the Stakes Ahead of RSSS's Earnings Call Aw, the sweet suspense of earnings season. Research Solutions, Inc. (NASDAQ: RSSS) has circled November 12, 2026, as the date to let investors in on its numbers for the first quarter of fiscal year 2027. A date that's gotta have the folks over at RSSS feeling like it’s judgment day. You know how it goes—market...

Continue Reading
Key Life Events That Demand a Financial Plan Change

Updated Category News Views 49

Navigating Life's Milestones with Financial Savvy Nothing stirs the financial pot quite like life's big events. The grind of daily life might trick you into thinking everything's fine, but ignore these milestones at your peril. Ted Thatcher, a financial advisor from Roseville, California, lays it out in HelloNation's latest foray into sound financial planning: your...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 55

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Array Digital's Q3 2026 Earnings: Strategic Wins and Challenges

Updated Category News Views 36

From Towers to Earnings: Array Digital's 2026 Path Array Digital Infrastructure, Inc. (NYSE:AD) just rolled out its Q3 2026 numbers, and honestly, it's a mixed bag. This company is one of those handy barometers for the telecom infrastructure market, especially now that it's a full-blown tower company. They've pitched an earnings call for the early birds at 9 a.m. CT...

Continue Reading
Deep Principle's Hydrogen-1.0: A Leap in AI-Driven Chemistry

Updated Category News Views 101

Leaving Old Lab Notebooks in the Dust Deep Principle just shook up the science lab with their latest brainchild, Hydrogen-1.0. We're talking about an AI-driven marvel designed to tackle chemistry and materials research like no traditional lab rat ever could. On November 4, they rolled out this bad boy—an open-weight model fine-tuned to turn vague scientific hunches into...

Continue Reading
S&P 500 Drop: A Market Glitch or Future Trend?

Updated Category News Views 34

A Sudden Jolt in a Trending Market Mornings like these make you question your coffee strength. A major market dip, with the S&P 500 shedding 3.51%, is like a slap to the face, especially when the Nasdaq Composite takes a 5.24% nosedive. The Dow isn't spared, dropping 2.45%. But, let's not lose our heads here. Today is a blip, a pixel in the bigger picture where the S&P...

Continue Reading
UP Fintech Faces 25% Stock Drop Amid Fraud Suit

Updated Category News Views 67

Stock Market Whiplash: UP Fintech's Rough Ride You know, just when you think you've seen it all in this bonkers stock market world, something like a 25% drop in UP Fintech’s stock reminds you that surprises never end. Now, UP Fintech’s facing a class action lawsuit, alleging it didn’t exactly play fair, sparking this latest rollercoaster ride. Yeah, buckle up folks,...

Continue Reading
Gildan Class Action: What Investors Should Know

Updated Category News Views 9

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Continue Reading

Top 5 Most Recently Viewed Articles

Americas CarMart Sees Director Buy Shares Amid Company Changes

Updated Category News Views 124

Director's Stock Purchase at Americas CarMart Americas CarMart Inc. (NASDAQ: CRMT) has recently caught the public's attention as director Ann G. Bordelon purchased shares worth $52,976. This acquisition signals a strong confidence in the used car dealership's ability to face the competitive market and continue on its path toward growth and success. The Acquisition Details...

Continue Reading
Scully Royalty Reports Half-Year Results and announces Dividend

Updated Category News Views 94

Scully Royalty Ltd. Half-Year Financial Report Insights Scully Royalty Ltd. (NYSE: SRL) has recently published its half-year report, detailing its financial results for the six months concluded. The report, referred to as the Half-Year Report, reflects the company's business performance and strategic updates. Dividend Declaration and Financial Performance In conjunction...

Continue Reading
Inozyme Pharma's 2024 Financial Update and Future Focus

Updated Category News Views 154

Inozyme Pharma's Strategic Vision for 2024 Inozyme Pharma, Inc. (NASDAQ: INZY) is making significant strides as it navigates the dynamic landscape of biotechnology. The company specializes in developing breakthrough therapeutics tailored for rare diseases impacting bone health and vascular function. As of December 31, 2024, Inozyme announced its financial results...

Continue Reading
Strategy Inc Partners with Snowflake for AI Data Solutions

Updated Category News Views 245

Strategy Inc and Snowflake Team Up for Enhanced Data Management Strategy Inc (NASDAQ: MSTR) has announced its partnership with Snowflake Inc (NYSE: SNOW) to establish a more standardized framework for managing data effectively. This collaboration aims to simplify and streamline the data landscape through the Open Semantic Interchange (OSI) Advancing Open Data Standards As...

Continue Reading
Innovative Industrial Properties Faces Legal Challenges Ahead

Updated Category News Views 129

Innovative Industrial Properties Legal Challenges Shareholders of Innovative Industrial Properties, Inc. (NYSE: IIPR) are currently navigating a troubling period as the company faces a lawsuit for securities law violations. This situation raises important questions for investors who may be affected. Class Period and Allegations The allegations against IIPR highlight...

Continue Reading